thalidomide
Commercial- Indications
- Multiple myeloma, Erythema nodosum leprosum
Company intelligence / Profile preview
Laphal Industries is an established French CDMO specializing in the manufacturing of pharmaceuticals and dietary supplements. The company operates two main production sites focused on liquid forms and oral solid dosage forms. It offers regulatory support, analytical testing, packaging, logistics/distribution services, and has expanded its capabilities with the acquisition of Laboratoires Pasquier in 2015. No proprietary clinical results are reported since it does not develop its own drugs.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laphal Industries.